Embelin decreased the constitutive phosphorylation/activation levels of PI3K/AKT in bladder cancer, pancreatic cancer, and leukemia [57,87,88], and inhibited cell growth by inducing apoptosis via the PI3K/AKT pathway. The gene discussed is AKT1; the disease is urinary bladder cancer.